Skip to main content

Challenges of managing hypertension in Pakistan - a review



This review aims to describe existing evidence on the state of hypertension in Pakistan, including the prevalence, associated risk factors, preventive strategies, and challenges in the management of hypertension.


A comprehensive literature search was conducted electronically using PubMed and Google Scholar. Using specific screening methodology, 55 articles were selected to be included.


We found from this extensive review that several small studies report high prevalence of hypertension but there is a lack of population based prevalence of hypertension in Pakistan. Lifestyle risk factors such as obesity, unhealthy diet, decreased physical activity, low socioeconomic status, and lack of access to care were the main associated factors with hypertension. Lack of blood pressure monitoring practices and medication non-adherence were also linked to uncontrolled hypertension in Pakistan and were more evident in primary care setups. The evidence presented is essential for delineating the burden of the disease, hence allowing for better management of this underserved population.


There is a need for updated surveys to depict the true prevalence and management of hypertension in Pakistan. Cost-effective implementation strategies and policies at the national level are needed for both prevention and control of hypertension.


Hypertension is a leading cause of the global burden of non-communicable diseases and a significant contributor to cardiovascular disease, chronic kidney disease, and stroke [1]. Currently 25% of the world’s adult population is hypertensive, which is predicted to rise to 29% by 2025 [2]. Systematic analysis using population-based studies from 90 countries reported the prevalence of hypertension as 31.5% in low-and-middle-income countries (LMIC), compared to 28.5% in high-income countries [3]. Not only is the prevalence of hypertension growing in developing countries, but the age of onset of cardiovascular disease (including hypertension) is decreasing [2], and thus contributes to about two-thirds of the mortality attributed to hypertension [4]. A study from the second National Diabetes Survey of Pakistan (NDSP) 2016, concluded an alarming prevalence of hypertension in Pakistan that urges immediate attention [5].

Hypertension exists alongside cardiovascular disease, and several behavioral and socio-demographic characteristics are seen to be linked with both [6]. Cardiovascular disease (CVD) is consistently evolving and will be the foremost cause of mortality in 2030 [7]. Despite the seriousness of cardiovascular diseases, minimal attention is directed towards the prevention of its risk factors, including hypertension. Pakistan is a country in South Asia and is the fifth most populous country in the world [8]. The healthcare system of Pakistan consists of a private sector (70%) and a public sector (30%). Only 27% of the population benefits from full healthcare coverage, whereas 73% depend on out-of-pocket payments [9, 10]. Economic and political instability is a leading cause for inadequate preventive and control strategies, thus accelerating rates of hypertension and cardiovascular diseases in this country [11]. This review aims to describe the existing state of hypertension in Pakistan, including its prevalence, associated factors for control of hypertension, and evidence on management of hypertension.

Main text

This review includes articles from PubMed and google scholar search engines and bibliography yielded 44,170 articles out of which 55 articles were selected using the screening methods shown in Fig. 1. Table 1 lists some of the main studies included in this review.

Fig. 1
figure 1

Study flow chart—articles and bibliography

Table 1 Summary of studies on hypertension in Pakistan

Prevalence of hypertension in Pakistan

Hypertension in adults

We still await a large population-based survey to record the prevalence of hypertension in the existing 216 million population in Pakistan. According to the last population-based National Health Survey of Pakistan (NHSP), nearly 18.9% of people in Pakistan above 15 years were hypertensive, with a higher prevalence in urban populations than rural population, and in men more than women [12]. Despite the lack of population-based data on hypertension prevalence, multiple studies have been conducted to determine the prevalence of hypertension sporadically in multiple provinces and cities of Pakistan. The WHO Stepwise approach to surveillance (STEPS) was conducted in the two large provinces, Sindh and Punjab, and reported a prevalence of stage 1 hypertension (SBP > 140 mmHg and DBP > 90 mmHg) to be 37% and stage II hypertension (SBP > 160 mmHg and DBP > 100 mmHg) to be 15.9% [12]. More recently in the National Diabetes Survey of Pakistan (NDSP) 2016–2017, a large community-based epidemiological survey in all four provinces (n = 10,834), the prevalence of hypertension was 46.2% [5]. Other small-scale urban studies reported prevalence ranging from 15 to 29% [13, 14]. Furthermore, the high rates of uncontrolled hypertension in Pakistan, which represented more than one-fourth of all patients in the medical emergency department, inevitably lead to hypertensive crises in 56.3% of these patients [15].

Hypertension in children and adolescents

Hypertension is not just limited to adults. There is a disproportionately higher blood pressure (BP) burden in South Asian children with relatively unclear reasons [16]. Jafer et al. reported that increased obesity in children was associated with elevated levels of BP in South Asia [17, 18]. These differences persisted even with lower Body Mass Index (BMI) thresholds, and children at or above these thresholds were twice as likely to have an increase in BP than those not centrally obese or overweight [18]. Furthermore, elevated blood pressure during childhood is considered a predictor of hypertension during adulthood [19]. A study comparing blood pressure in South Asian children versus American children, found that 12.2% of Pakistani children between ages 5 and 14 years have high blood pressure; significantly higher than children in the United States (p < 0.001) [20]. This finding was observed despite Pakistani children having lower BMIs. Bilal M et al. conducted a study on one thousand children who visited an outpatient clinic in 2019 in urban Karachi and reported a 25% prevalence of Hypertension (HTN) in children aged between 4 and 7 years, and pre-HTN in 10% [21]. It also showed a strong association between HTN in children and weight, family history, and high-fat diet, concluding that large-scale screening of young children is required to report the prevalence of elevated blood pressures.

In summary, the prevalence of hypertension is high in Pakistan, with almost 2/3rds of presenting patients suffering from it. From 2000 to 2010, the prevalence of hypertension decreased by 2.6% in high-income countries but increased by 7.7% in low/middle–income countries [22]. A study reported an increasing prevalence of 46.2% in Pakistan in 2016–2017. Reviews done in other low-middle income countries in 2017 showed a similar increase with time, such as 40.6% in India [23], 40.7% in Bangladesh [24], and 34.0% in Zambia [25]. The main reasons for this rise are disparities in awareness, treatment, and control rates, due to the lack of resources, education, and funds in low-middle income countries [26]. Our study reflects this data and Pakistan is shown to be one of the low-middle income countries continuously struggling with these health disparities.

Risk factors for hypertension in Pakistan

A meta-analysis of 37 studies extracted 46 factors that were significantly associated with hypertension in the Pakistani population [27]. The three most frequently reported factors were old age (15), gender (14), and BMI (9) [27]. A national Non-Communicable Disease (NCD) survey for risk factors in two major provinces of Pakistan found a high prevalence of HTN, with the respondents having either low fruit and vegetable consumption (96.5%), low physical activity (46%), being overweight (26.3%), or obesity (14.9%) [13].


The association of BMI with hypertension has been reported in multiple studies, specifically a BMI greater than 23 kg/m2 [28]. Akram J et al. noted obesity prevalence in Pakistan was 70% and had significant association with hypertension (HTN) (p = 0.0003) [29]. They also found obesity was higher among Pakistani women than men. The childhood obesity epidemic has caused the global prevalence of (HTN) in children to increase from 2 to 4% [21]. However, there is limited data on obese children and HTN in Pakistan.

Unhealthy diet

The Pakistan Adolescents Schools Survey 1 reported that over 80% of adolescents in Pakistan had unhealthy diets [30]. Studies in high-income populations have shown that diets high in red meat, fatty food, and sweet desserts are associated with an increase in blood pressure, whereas diets with high amounts of fruits, vegetables, whole grains, and lean meat are associated with lower blood pressure [31]. However, Asian populations have different environmental and genetic factors, and few studies have been done in this population, assessing the role of dietary patterns on hypertension. A study on the Pakistani population reported a decrease in HTN with yogurt and seafood dietary patterns, but no statistically significant effect between high-fat and sugar dietary patterns and hypertension [32]. The same study also did not find a significant effect of high fruit and vegetable diet on blood pressure reduction in the Pakistani population.

Physical inactivity

A WHO study showed that 82.8% of boys and 87.3% of girls aged 13‐15 are not sufficiently active [33]. 54.3% of Pakistani adolescents are physically inactive according to another study [30]. Schools without playgrounds, female gender, and lack of parental support for sports correlated with physical inactivity among the students [34]. In a cross-sectional survey in Karachi, physical activity was significantly associated with a lower risk of hypertension [35]. Men were more likely to be more active, as culturally they have greater access to the outdoor facilities compared to the women. These findings highlight the need for increased physical activity and its relevance and contributions to hypertension.

An assessment of 21 countries reports that the main reason contributing to these risk factors could be the reinforcement of sedentary lifestyles through new technology, increased office jobs, conversion of agricultural lands to factories, and transportation facilities that make physical activity more difficult [36].

Literature reports established risk factors for hypertension, including lifestyle behaviors, physical inactivity, unhealthy diet, obesity, low socioeconomic level, and smoking [36]. Results from this review are consistent with literature, with a particular emphasis on obesity, unhealthy diet, and decreased physical activity, all of which in turn can also be attributed to low socioeconomic level. Global reviews have displayed that in high-income countries, the decline in blood pressure has occurred despite rising BMI, whereas both BMI and blood pressure are rising in most LMIC [26, 37, 38]. This can be explained by enhanced social and economic development, including the availability of nutritious food options, better housing infrastructure, and importance given to early childhood and adolescent nutrition in high income countries [39,40,41,42]. LMIC must look to higher income countries to adopt strategies used to reduce risk factors. An Example of addressing specific risk factors is the reduction of salt intake in the Republic of South Africa, where legislation was passed on the limitation of the upper limit of sodium content in processed foods [43]. Lifestyle changes are a crucial and actionable risk factor and must be emphasized by both the medical professionals and government agencies of Pakistan, where counseling and education can improve the compliance and sustainability of healthy habits.

Blood pressure monitoring practice in Pakistan

According to the European Society of Cardiology (ESC) 2018 guidelines, auscultatory or oscillometric semiautomatic or automatic sphygmomanometers are the preferred method for measuring BP [44]. Oscillometric devices are recommended for office BP as they give the best results. However, due to the enhanced cost requirements, it cannot be recommended as the primary method in resource-poor countries [45]. Low-income countries such as Pakistan continue to use the mercury sphygmomanometer despite its multiple problems. Studies in this setting report wide variation in blood pressure monitoring in clinic settings with white coat hypertension reported in 16% of patients [46]. Moreover Shahab et al. introduced the concept of Post-clinic BP, as it had a good correlation with ambulatory BP and may be considered a more reliable method of monitoring BP [47].

Control rate of hypertension in Pakistan

Hypertension control is poor in most Asian countries [48]. In primary care settings, developed countries like Canada have a higher percentage of patients with controlled hypertension (65%) compared to developing nations like Pakistan, where the control rate is 6% [49]. According to the National Health Survey of Pakistan, 17.9% of adults over 15 years had hypertension, and from those only 3% had hypertension under control [50]. The proportion of patients with controlled hypertension differs among developed and developing countries, specifically between primary and tertiary settings. A cross-sectional study from rural areas of Pakistan, Bangladesh, and Sri Lanka showed that low adherence to antihypertensive therapy was one of the critical factors independently associated with high odds of uncontrolled BP [51]. Moreover, most individuals in each country were taking only one antihypertensive medication, due to affordability and availability. Rates of control are better in tertiary care settings. A study coordinated in three different tertiary care centers in Karachi reported that 72.3% of non-diabetic hypertensive patients had controlled BP, defined as an average BP of less than 140/90 mmHg [50]. Higher age, male gender, and greater than 10 years of formal education were significant factors leading to more controlled hypertension. A study from 2019 at a single-center tertiary center in Karachi reported that 62.5% of patients took antihypertensive medication daily, and more than half of that studied population had their BP controlled [52]. Like other studies, this study discovered that gender, smoking, additional comorbidities, and medication compliance were significant factors associated with uncontrolled hypertension.

Challenges in controlling hypertension

The nonexistence of screening programs, problems in accessing health care facilities, lack of communication between provider and patient, and high treatment costs are substantial barriers to the hypertension control in Pakistan [53]. A qualitative study conducted at Aga Khan Hospital, Karachi, found that lack of insight about disease seriousness, deficiency in knowledge, health care system limitations, inadequate health education, financial constraints, religious belief, all acted as barriers to proper control of NCDs including hypertension [54]. In contrast, patients with higher education levels, family history of HTN, fear of premature death, and previous comorbidities were more likely to perform self-care behavior than newly diagnosed patients [54].

Medication nonadherence

Adherence is defined as the extent to which patients can follow the recommendations for prescribed treatments. Patients may become non-adherent when they decide not to fill their prescriptions, take less than the prescribed treatment, use their medication at the wrong time, or discontinue treatment prematurely [55]. Level of education, number of medications, and presence of comorbidities were significantly associated with medication adherence in Pakistan [56]. A cross-sectional study among individuals treated for hypertension in rural South Asia, and urban Pakistan, reported an independent relationship between low wealth index and poor adherence to medications with a higher likelihood of uncontrolled blood pressure [57, 58]. Another cross-sectional study evaluating drug compliance and associated factors in patients from Karachi found that patients stopped taking medication when they traveled away from home and when symptoms were controlled [59]. The study also found that male gender, duration of hypertension of more than 5 years, and regular BP monitoring were associated with higher rate of compliance.

Lack of universal health care (UHC)

UHC means that all individuals and communities receive the health services they are entitled to without suffering financial hardship. It includes the full spectrum of essential, quality health services, from health promotion to prevention, treatment, rehabilitation, and palliative care across the life course [60]. Unfortunately, in Pakistan, the majority of the healthcare cost burden is incurred by the household, as 60% of the total health expenditures come from out-of-pocket (OOP) expenditures, with the largest (> 52%) share of OOP expenditure being medication [61]. A study in Pakistan, showed that blood pressure and diabetes medication were a substantial portion of household expenditures, competing with other necessities such as food and education [61]. The percentage of uncontrolled hypertension was higher in rural Pakistan compared to Bangladesh and Sri Lanka, due to scarce use of antihypertensive medications in Pakistan with a lack of universal health coverage, and where more than 80% of spending on medications is out-of-pocket (OOP) [51]. In Karachi, a study conducted to assess the OOP cost of treatment of hypertension found that the total cost for stage I and II hypertension was 217,869.7PKR and 17,545,457.6 PKR, respectively, demonstrating that cost alone causes an increased burden on the average-earning man, ultimately resulting in medication nonadherence [62].

Lack of knowledge about hypertension

A study conducted at three tertiary centers in Karachi, Pakistan, found that the knowledge score in hypertensive patients was poor and even lower in those with uncontrolled hypertension [63]. The mean physician encounter score was seen to be higher in controlled hypertensive patients compared to those with uncontrolled hypertension (p < 0.05), depicting better physician-patient communication results in sufficient medication adherence and ultimately improved control of hypertension [63]. Statistically significant differences in knowledge between patients with controlled and uncontrolled hypertension was observed, with regards to the meaning of hypertension, target systolic and diastolic blood pressures, hypertension being a lifelong disease with lifelong treatment, asymptomatic hypertension, lifestyle changes, and high blood pressure associated with aging [50]. Another study comparing knowledge and attitude toward hypertension between patients in primary care settings and patients in tertiary care hospitals found marked differences between the two groups, in importance of medication adherence and the role of diet, exercise, and weight reduction on BP management [64]. The difference between the patients in these two settings was explained by their education level, as a significant number of patients visiting Primary Healthcare Center (PHC) had no, or minimal education [64]. There can be multiple reasons for the lack of knowledge about hypertension in our population. Lack of patient education by the physician, lack of health education through media, and lack of proper infrastructure and resources are a few [50]. A study conducted in Lahore, Pakistan, to evaluate the effect of educational intervention on the control of BP found that after the intervention there was an increase in medication adherence, and lower systolic and diastolic blood pressure [65]. Hence, it is necessary to increase patient knowledge, and the physician plays a critical role in this.

Evidence on management of hypertension in Pakistan

The widely recommended treatment of initial hypertension involves the use of Thiazide Diuretics, Angiotensin-Converting Enzyme Inhibitors (ACEIs), or Calcium Channel Blockers (CCBs) [66]. The Joint National Committee (JNC) guidelines recommend the use of thiazide diuretics for most patients [67], whereas Pakistan Hypertension League’s guidelines, which resemble the National Institute for Health and Care Excellence (NICE) guidelines, recommend that patients younger than 55 years of age should be treated with ACEIs and those older than 55 years or the black population, should be treated with CCB and diuretics [68]. Diuretics are recommended due to their safety profile, cost-effectiveness, and cardiovascular protection [68]. Beta-blockers are now not recommended for the initial treatment of hypertension due to their diabetogenic potential [68]. But Pakistani doctors did not adhere to pharmacologic treatment guidelines as beta-blockers were prescribed most extensively (33%), followed by ACEI (18%) and CCBs (13%), whereas thiazide diuretics were hardly used [68]. This is despite hydrochlorothiazide from a national company being the most cost-effective drug for a patient [68]. Furthermore, up to four times more expensive branded generics were commonly prescribed and would translate into increased cost of treatment [68]. In another study, only 3.7% of doctors talked about the Dietary Approaches to Stop Hypertension (DASH) diet with their patients or were advising salt reduction to hypertensive patients. Furthermore, smoking cessation counseling to hypertensive patients was mentioned by only 4.3% of doctors [69]. A recent systematic review on prescribing antihypertensive patterns in Pakistan, from a total of 26 studies from 2000 to 2018, concluded that only ten studies utilized national or international guidelines a better understanding of a clinician’s perception and practice of hypertension management guidelines in LMICs is needed [70].

Intervention trials on hypertension from Pakistan

Limited intervention trials on hypertension management have been done in Pakistan so far. A cluster randomized control trial conducted in 12 communities of Karachi showed that among the population between the ages of 5 and 39 years, significant systolic and diastolic blood pressure reduction occurred in the intervention group which received home health education (HHE) in a public health setting [71]. The trial also demonstrated that among adult hypertensive patients, there was a greater proportion of patients achieving controlled blood pressure and a greater drop witnessed in systolic BP in patients who received both HHE and general practitioner education combined than those who received either HHE or general practitioner education or none [71]. Thus, this trial highlighted the importance of combined community education and caretaker (GP) education in controlling hypertension in Pakistan. A two-arm cluster randomized control trial in a private health sector in Punjab exhibited enhanced management of hypertension in the intervention group that received a clinical guide with standardized prescription, adherence support, and lifestyle modifications [72]. The trial also found a significant increase in the proportion of patients with controlled hypertension and higher treatment adherence in the intervention arm than in the control arm. Both these studies highlight the importance of public-private partnership to implement hypertension control at a mass level. Table 1 summarizes the existing studies on hypertension conducted in Pakistan.

In summary, there are many barriers to the successful management of hypertension in resource-limited settings and a lack of trials on how to overcome them. There is a need for changes in policymaking to allow for the management of hypertension through cost-effective strategies, preventative health promotions, providing affordable treatment, and updating therapeutic guidelines [19, 61, 62]. The Community-Based Intervention for Managing Hypertension in Rural South Asia study by Jafer et al. has shown success of a multicomponent intervention based on home visits by trained government community health workers and led to a greater reduction in blood pressure than usual care among adults with hypertension [17]. This model has also been tested in other South Asian countries including Sri Lanka and Bangladesh.

In other studies from Pakistan, the need for medical advancements and research and improvement in healthcare delivery is shown to be of extreme importance to achieve control of hypertension. This would involve focusing on preventative care with regular BP screening, effective communication by the providers, standardized treatment approaches, providing cost-effective treatment, and ensuring accountability [73]. Pakistan’s neighboring country, India, has reported that awareness, treatment, and control are lower in populations with primary or no education, reflecting a combination of low socioeconomic status, which may influence access to care, lack of knowledge of the sequelae of uncontrolled hypertension, and differing values concerning the importance of blood pressure control [74]. Ultimately treatment coverage and effectiveness remain low in low-income settings [75]. Socioeconomic inequality in LMIC affects the use of drugs and secondary prevention medicines [76].

Better developed health systems, such as in the United States of America where there is more socioeconomic stability, are more effective in managing HTN [77, 78]. There is an increased need for government and policymakers to make available the resources necessary to build on the existing healthcare infrastructure. This means building both physical and human resource capacity, as well as the use of several non-traditional hypertension screening methods. An example of such a model has been successful in several LMICs through programs spearheaded by the Global Alliance for Chronic Disease [79]. Further trials on hypertension management are necessary for establishing guidelines and recommendations catered to low- and middle-income countries.

The strength of this review is that it is a comprehensive search of databases to ensure all relevant articles were identified. Potential bias was reduced by having the authors independently scan through the search output and extract relevant data. Some limitations are that the probability that health outcomes such as hypertension may influence reports of smoking, drinking habits and other lifestyle factors, and not vice versa, cannot be disregarded. Most studies included in this review are cross sectional, and their design does not affirm causality. Studies included in this review varied in design, population, assessment of risk factors, and timeframe of the sample collected, hindering the ability to compare results. Moreover, the different methods of identification of hypertensive patients could misjudge the true prevalence, especially when hypertension was self-reported. There is a large amount of heterogeneity in data, due to which a meta-analysis could not be done.


Pakistan is shown to be one of the low-middle income countries continuously struggling with health disparities including hypertension control. Although the prevalence of hypertension is proven to be high in Pakistan, more robust population-based survey prevalence figures are lacking. There is a need for updated surveys to depict the true prevalence and control rate of hypertension in Pakistan and implementation strategies for hypertension control across the country.

Implementation of studies like the Community-Based Intervention for Managing Hypertension in Rural South Asia across the country are study needed for prevention and management of hypertension across Pakistan. Digital health technology must be tested and implemented in blood pressure control models in future, as these actions have shown proven benefits in other countries.

Lifestyle risk factors and low socioeconomic level are the leading barriers to HTN management in Pakistan. LMIC must look to higher income countries to adopt strategies used to reduce risk factors. Lifestyle changes are a crucial and actionable risk factor and must be emphasized by both medical professionals and government agencies of Pakistan, where counseling and education can improve compliance and sustainability of healthy habits.

There is a need for changes in policymaking to allow for the management of hypertension through cost-effective strategies, preventative health promotions, providing affordable treatment, updating therapeutic guidelines and ensuring the implementation of guidelines by healthcare professionals. The categorization of Pakistan as a LMIC, and thus having weak policymaking and implementation, is the root of most health disparities in the country.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the study.





Angiotensin-Converting Enzyme Inhibitors


Calcium Channel Blockers


World Health Organization Stepwise Approach to surveillance


National Diabetes Survey of Pakistan


Cardiovascular disease


Low-and-middle-income countries

BP :

Blood Pressure


Body Mass Index


European Society of Cardiology


Non-Communicable Disease


Universal Health Care




Joint National Committee


National Institute for Health and Care Excellence


Dietary Approaches to Stop Hypertension


Primary Healthcare Center


Home Health Education


  1. Yao Q, Liu C, Zhang Y, Xu L. Health-related quality of life of people with self-reported hypertension: a national cross-sectional survey in China. Int J Environ Res Public Health. 2019;16(10):1721.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet (London, England). 2005;365(9455):217–23.

    Article  PubMed  Google Scholar 

  3. Mohsen IM. Hypertension in developing countries: a major challenge for the future. Curr Hypertens Rep. 2018;20(5):38.

    Article  Google Scholar 

  4. Prabhakaran D, Jeemon P, Ghosh S, Shivashankar R, Ajay VS, Kondal D, et al. Prevalence and incidence of hypertension: results from a representative cohort of over 16,000 adults in three cities of South Asia. Indian Heart J. 2017;69(4):434–41.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Basit A, Tanveer S, Fawwad A, Naeem N, NDSP Members. Prevalence and contributing risk factors for hypertension in urban and rural areas of Pakistan; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017. Clin Exp Hypertens. 2020;42(3):218–24.

    Article  PubMed  Google Scholar 

  6. Shafi ST, Shafi T. A survey of hypertension prevalence, awareness, treatment, and control in health screening camps of rural central Punjab, Pakistan. J Epidemiol Glob Health. 2017;7(2):135–40.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cardiovascular diseases. Available from: Cited 2022 Dec 26.

  8. Pakistan - Wikipedia. Available from: Cited 2022 Dec 25.

  9. Hassan A, Mahmood K, Allah Buksh H. Healthcare system of Pakistan. Int J Adv Res Publ. 2017;1(4):170-3.

  10. WHO EMRO | Health service delivery | Programmes | Pakistan. Available from: Cited 2022 Dec 26.

  11. Barolia R, Sayani AH. Risk factors of cardiovascular disease and its recommendations in Pakistani context. J Pak Med Assoc. 2017;67(11):1723–9.

    PubMed  Google Scholar 

  12. Rafique I, Saqib MAN, Munir MA, Qureshi H, Rizwanullah KS, Khan SA, et al. Prevalence of risk factors for noncommunicable diseases in adults: key findings from the Pakistan STEPS survey. East Mediterr Health J. 2018;24(1):33–41.

    Article  PubMed  Google Scholar 

  13. Siddiqui H, Anjum Q, Omair A, Usman J, Rizvi R, Ashfaq T. Risk factors assessment for hypertnesion in a squatter settlement of Karachi. J Pak Med Assoc. 2005;5(9):390–2.

    Google Scholar 

  14. Ishtiaq S, Ilyas U, Naz S, Altaf R, Afzaal H, Muhammad AS, et al. Assessment of the risk factors of hypertension among adult & elderly group in twin cities of Pakistan. J Pak Med Assoc. 2017;67(11):1664–9.

    PubMed  Google Scholar 

  15. Almas A, Ghouse A, Iftikhar AR, Khursheed M. Hypertensive crisis, burden, management, and outcome at a tertiary care center in Karachi. Int J Chronic Dis. 2014;2014:1–7.

    Article  Google Scholar 

  16. Fowokan A, Punthakee Z, Waddell C, Rosin M, Morrison KM, Gupta M, et al. Multifactorial correlates of blood pressure in South Asian children in Canada: a cross-sectional study. BMJ Open. 2019;9(4):e027844.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, et al. A community-based intervention for managing hypertension in rural South Asia. N Engl J Med. 2020;382(8):717–26.

    Article  PubMed  Google Scholar 

  18. Jafar TH. Children, obesity, and high blood pressure: Asian populations at high risk. Am J Hypertens. 2009;22(1):6–7.

    Article  PubMed  Google Scholar 

  19. Jafar TH, Islam M, Hatcher J, Hashmi S, Bux R, Khan A, et al. Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial. BMJ. 2010;340(jun07 1):c2641.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Jafar TH, Islam M, Poulter N, Hatcher J, Schmid CH, Levey AS, et al. Children in south Asia have higher body mass-adjusted blood pressure levels than white children in the United States. Circulation. 2005;111(10):1291–7.

    Article  PubMed  Google Scholar 

  21. Bilal M, Haseeb A, Saeed A, Saeed A, Ghaffar P. Prevalence and risk factors of hypertension among children attending out patient department of a tertiary care hospital in Karachi. Cureus. 2020;12(5):e7957.

    PubMed  PubMed Central  Google Scholar 

  22. Bloch MJ. Worldwide prevalence of hypertension exceeds 13 billion. J Am Soc Hypertens. 2016;10(10):753–4.

    Article  PubMed  Google Scholar 

  23. Abariga SA, Khachan H, Al Kibria GM. Prevalence and determinants of hypertension in India based on the 2017 ACC/AHA guideline: evidence from the India National Family Health Survey. Am J Hypertens. 2020;33(3):252–60.

    Article  PubMed  Google Scholar 

  24. Islam JY, Zaman MM, Haq SA, Ahmed S, Quadir ZA. Epidemiology of hypertension among Bangladeshi adults using the 2017 ACC/AHA hypertension clinical practice guidelines and joint National Committee 7 guidelines. J Hum Hypertens. 2018;32(10):668–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Goma FM, Mwewa B, Tembo GK, Kachamba M, Syatalimi C, Simweemba C, et al. May measurement month 2017: blood pressure screening results from Zambia-Sub-Saharan Africa. Eur Heart J Suppl. 2019;21(Suppl D):D130–2.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–802.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Riaz M, Shah G, Asif M, Shah A, Adhikari K, Abu-Shaheen A. Factors associated with hypertension in Pakistan: a systematic review and meta-analysis. PLoS One. 2021;16(1):e0246085.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Jafar TH, Chaturvedi N, Pappas G. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. Can Med Assoc J. 2006;175(9):1071–7.

    Article  Google Scholar 

  29. Akram J, Rehman HR, Muneer F, Hassan S, Fatima R, Khan TM, et al. Hypertension and obesity: a cross-sectional study. Eur J Med Heal Sci. 2021;3(4):90–4.

    Google Scholar 

  30. Khuwaja AK, Khawaja S, Motwani K, Khoja AA, Azam IS, Fatmi Z, et al. Preventable lifestyle risk factors for non-communicable diseases in the Pakistan Adolescents Schools Study 1 (PASS-1). J Prev Med Public Health. 2011;44(5):210–7.

    Article  PubMed  Google Scholar 

  31. Mansoori S, Kushner N, Suminski RR, Farquhar WB, Chai SC. Added sugar intake is associated with blood pressure in older females. Nutrients. 2019;11(9):2060.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Safdar N, Bertone-Johnson E, Cordeiro L, Jafar T, Cohen N. Dietary patterns and their association with hypertnesion among Pakistani urban adults. Asia Pac J Clin Nutr. 2015;24(4):710–9.

    CAS  PubMed  Google Scholar 

  33. World Health Organization. Regional Office for the Eastern Mediterranean. Country factsheet insufficient physical activity. Pakistan; 2015.

  34. Jabeen I, Zuberi R, Nanji K. Physical activity levels and their correlates among secondary school adolescents in a township of Karachi, Pakistan. J Pak Med Assoc. 2018;68(5):737–43.

    PubMed  Google Scholar 

  35. Ajani K, Gowani A, Gul R, Petrucka P. Levels and predictors of self-care among patients with hypertension in Pakistan. Int J Gen Med. 2021;14:1023.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Zibara V, Costanian C, Al Haddad N, Kilani H, Tohme F, Bahous SA. Epidemiology and management of hypertension among refugees in the Middle East: a review of the literature. J Hum Hypertens. 2021;35(8):657–66.

    Article  PubMed  Google Scholar 

  38. Bentham J, Di CM, Bilano V, Bixby H, Zhou B, Stevens GA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet (London, England). 2017;390(10113):2627–42.

    Article  Google Scholar 

  39. Ezzati M, Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, et al. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018;47(3):872–883i.

    Article  Google Scholar 

  40. Micha R, Khatibzadeh S, Shi P, Andrews KG, Engell RE, Mozaffarian D. Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide on behalf of the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group. Nutri Open. 2015;5:1-23.

  41. Lewington S, Li L, Sherliker P, Guo Y, Millwood I, Bian Z, et al. Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank. J Hypertens. 2012;30(7):1383.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bentham J, Di Cesare M, Stevens GA, Zhou B, Bixby H, Cowan M, et al. A century of trends in adult human height. Elife. 2016;5. Available from: Cited 2022 Dec 26.

  43. Peters SAE, Dunford E, Ware LJ, Harris T, Walker A, Wicks M, et al. The sodium content of processed foods in South Africa during the introduction of mandatory sodium limits. Nutrients. 2017;9(4):404.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.

    Article  PubMed  Google Scholar 

  45. Siddique S, Hameed Khan A, Shahab H, Zhang Y, Chin Tay J, Buranakitjaroen P, et al. Office blood pressure measurement: a comprehensive review. J Clin Hypertens. 2021;23(3):440–9.

    Article  Google Scholar 

  46. Godil SS, Tabani H, Khan AH, Almas A. White coat hypertension is not a benign entity: a cross-sectional study at a tertiary care hospital in Pakistan. J Pak Med Assoc. 2011;61(9):938–43.

    PubMed  Google Scholar 

  47. Shahab H, Khan HS, Almas A, Tufail M, Kazmi KA, Khan AH. The Post Clinic Ambulatory Blood Pressure (PC-ABP) study correlates Post Clinic Blood Pressure (PCBP) with the gold standard Ambulatory Blood Pressure. BMC Res Notes. 2018;11(1):460.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Chia Y, Kario K, Turana Y, Nailes J, Tay JC, Siddique S, et al. Target blood pressure and control status in Asia. J Clin Hypertens. 2020;22(3):344–50.

    Article  Google Scholar 

  49. Nadeem MK, Mari A, Iftikhar S, Khatri A, Sarwar T, Patel MJ. Hypertension-related knowledge and its relationship with blood pressure control in hypertensive patients visiting a semi-private tertiary-care charity hospital in Karachi, Pakistan. Cureus. 2019;11(10):e5986.

    PubMed  PubMed Central  Google Scholar 

  50. Almas A, Godil SS, Lalani S, Samani ZA, Khan AH. Good knowledge about hypertension is linked to better control of hypertension; a multicentre cross sectional study in Karachi, Pakistan. BMC Res Notes. 2012;5(1):579.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Jafar TH, Gandhi M, Jehan I, Naheed A, de Silva HA, Shahab H, et al. Determinants of uncontrolled hypertension in rural communities in South Asia—Bangladesh, Pakistan, and Sri Lanka. Am J Hypertens. 2018;31(11):1205–14.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Khan MN, Soomro N, Ashraf T, Naseeb K, Kumar R, Bhatti U, et al. Perceptions and practices towards medication non-adherence among hypertensive patients: an observational study. Cureus. 2019;11(10):e5917.

    PubMed  PubMed Central  Google Scholar 

  53. Legido-Quigley H, Naheed A, de Silva HA, Jehan I, Haldane V, Cobb B, et al. Patients’ experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: a qualitative study. PLoS One. 2019;14(1):e0211100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Gowani A, Ahmed HI, Khalid W, Muqeet A, Abdullah S, Khoja S, et al. Facilitators and barriers to NCD prevention in Pakistanis-invincibility or inevitability: a qualitative research study. BMC Res Notes. 2016;9:282.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Hugtenburg J, Vervloet M, van Dijk L, Timmers L, Elders. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;675-82.

  56. Almas A, Hameed A, Ahmed B, Islam M. Compliance to antihypertensive therapy. J Coll Physicians Surg Pak. 2006;16(1):23–6.

    PubMed  Google Scholar 

  57. Almas A, Patel J, Ghori U, Ali A, Edhi AI, Khan MA. Depression is linked to uncontrolled hypertension: a case–control study from Karachi, Pakistan. J Ment Health. 2014;23(6):292–6.

    Article  PubMed  Google Scholar 

  58. Saqlain M, Riaz A, Malik MN, Khan S, Ahmed A, Kamran S, et al. Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients in Islamabad, Pakistan. Medicina (B Aires). 2019;55(5):163.

    Article  Google Scholar 

  59. Ali K, Adil SO, Soomro N, Bibi A, Kalam S. Drug compliance and its associated factors among hypertensive patients in Pakistan: a cross-sectional study. Hosp Pharm. 2018;53(6):389–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Universal Health Coverage. Available from: Cited 2022 Dec 26.

  61. Datta BK, Husain MJ, Fatehin S. The crowding out effect of out-of-pocket medication expenses of two major non-communicable diseases in Pakistan. Int Health. 2019;12(1):50–9.

    Article  Google Scholar 

  62. Aslam N, Shoaib MH, Bushra R, Farooqi FA, Zafar F, Ali H, et al. Out of pocket (OOP) cost of treating hypertension in Karachi, Pakistan. Pak J Pharm Sci. 2018;31(3(Supplementary)):1039–44.

    PubMed  Google Scholar 

  63. Almas A, Bhamani F, Khan AH. Better physician-patient communication; an important milestone in control of hypertension, a multicenter study from Karachi, Pakistan. J Coll Physicians Surg Pak. 2014;24(12):952–4.

    PubMed  Google Scholar 

  64. Ashfaq T, Anjum Q, Siddiqui H, Shaikh S, Vohra EA. Awareness of hypertension among patients attending primary health care centre and outpatient department of tertiary care hospital of Karachi. J Pak Med Assoc. 2007;57(8):396–9.

    PubMed  Google Scholar 

  65. Amer M, Rahman N, Nazir SR, Raza A, Riaz H, Sultana M, et al. Impact of pharmacist’s intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients. Pak J Pharm Sci. 2018;31(6 (Supplementary)):2607–16.

    PubMed  Google Scholar 

  66. Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, et al. Hypertension pharmacological treatment in adults: a world health organization guideline executive summary. Hypertension. 2022;79(1):293–301.

    Article  CAS  PubMed  Google Scholar 

  67. Schwartz GL, Sheps SG. A review of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Curr Opin Cardiol. 1999;14(2):161–8.

    Article  CAS  PubMed  Google Scholar 

  68. Hussain IM, Naqvi BS, Qasim RM, Ali N. Current trends in treatment of hypertension in Karachi and cost minimization possibilities. Pak J Med Sci. 2015;31(5):1021–6.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Mohydin B, Siddique S, Mumtaz K. Arterial hypertension management trends in Pakistan; cross-sectional observational study of a sample of Pakistani doctors. J Hypertens. 2021;39(Supplement 1):e162.

    Article  Google Scholar 

  70. Arshad V, Samad Z, Das J, Almas A, Rashid N, Virani SS, et al. Prescribing patterns of antihypertensive medications in low- and middle-income countries: a systematic review. Asia Pac J Public Health. 2021;33(1):14–22.

    Article  PubMed  Google Scholar 

  71. Majeed F, Kamal AK. Can community based interventions control hypertension in developing countries? What is the evidence from Pakistan? J Pak Med Assoc. 2012;62(3):301–2.

    PubMed  PubMed Central  Google Scholar 

  72. Khan MA, Khan N, Walley JD, Khan SE, Hicks J, Sheikh FI, et al. Enhanced hypertension care through private clinics in Pakistan: a cluster randomised trial. BJGP Open. 2019;3(1):bjgpopen18X101617.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Dzau VJ, Balatbat CA. Future of hypertension. Hypertension. 2019;74(3):450–7.

    Article  CAS  PubMed  Google Scholar 

  74. Zaman MJ, Patel A, Jan S, Hillis GS, Raju PK, Neal B, et al. Socio-economic distribution of cardiovascular risk factors and knowledge in rural India. Int J Epidemiol. 2012;41(5):1302–14.

    Article  PubMed  Google Scholar 

  75. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Murphy A, Palafox B, O’Donnell O, Stuckler D, Perel P, AlHabib KF, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. Lancet Glob Health. 2018;6(3):e292.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015;372(5):447–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Axon RN, Bradford WD, Egan BM. The role of individual time preferences in health behaviors among hypertensive adults: a pilot study. J Am Soc Hypertens. 2009;3(1):35–41.

    Article  PubMed  Google Scholar 

  79. Vedanthan R, Bernabe-Ortiz A, Herasme OI, Joshi R, Lopez-Jaramillo P, Thrift AG, et al. Innovative approaches to hypertension control in low- and middle-income countries. Cardiol Clin. 2017;35(1):99–115.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


Not Applicable.


National Institutes of Health, FOGARTY INTERNATIONAL CENTER


Author information

Authors and Affiliations



AA was responsible for designing the report protocol and writing the protocol, as well as providing feedback on all drafts. AE was responsible for writing the report, conducting the search, screening potentially eligible studies, extracting and analysing data, interpreting results, updating reference lists, and creating ‘Summary of studies on hypertension in Pakistan’ table. AAA was responsible for screening potentially eligible studies and contributed to writing the first draft. She contributed to extracting and analysing data and creating ‘Summary of studies on hypertension in Pakistan’ table. NA provided feedback on the report reviewed the analysis and made final edits. AHK contributed in designing the study and gave expert inputs. ZS contributed in interpretation of results and reviewed the final drafts. HS contributed in interpretation of results and editing subsequent versions. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Aysha Almas.

Ethics declarations

Ethics approval and consent to participate

Not Applicable.

Consent for publication

Not Applicable.

Competing interests

Authors declare there are no competing interests in relation to the work described in this report.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elahi, A., Ali, A.A., Khan, A.H. et al. Challenges of managing hypertension in Pakistan - a review. Clin Hypertens 29, 17 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: